Related Experiment Videos
Ventricular performance in diabetic rabbits with norepinephrine cardiomyopathy
Summary
Norepinephrine-induced cardiomyopathy (NE-CM) impairs left ventricular (LV) function in diabetic rabbits, causing significant depression during hypercapnia. Norepinephrine partially counters this, but the differential depression persists.
Area of Science:
- Cardiology
- Diabetology
- Pharmacology
Background:
- Diabetes mellitus is a growing global health concern.
- Diabetic cardiomyopathy is a recognized complication, but its interaction with other cardiac insults is less understood.
- Norepinephrine cardiomyopathy (NE-CM) serves as a model for studying cardiac stress.
Purpose of the Study:
- To investigate the impact of NE-CM on left ventricular (LV) performance in a rabbit model of diabetes mellitus.
- To assess the effects of NE-CM on cardiac function under normal conditions and during hypercapnia.
- To determine the inotropic responsiveness to norepinephrine in diabetic rabbits with and without NE-CM.
Main Methods:
- Diabetes mellitus was induced using alloxan monohydrate in rabbits.
- Norepinephrine infusion was used to create NE-CM in a subset of diabetic rabbits.
- Left ventricular (LV) function, including stroke volume (SV10), was assessed using LV function curves.
- Responses to hypercapnia and exogenous norepinephrine were evaluated.
Main Results:
- Diabetic rabbits with NE-CM exhibited significantly reduced mean SV10 compared to control diabetic rabbits (0.95 vs. 1.22 ml, P < 0.05).
- NE-CM markedly blunted the increase in LV dP/dt max in response to norepinephrine infusion.
- Hypercapnia induced significantly greater ventricular depression in NE-CM rabbits compared to controls (P < 0.001).
Conclusions:
- NE-CM significantly impairs LV pump function in diabetic rabbits.
- Diabetic hearts with NE-CM are more susceptible to the depressive effects of hypercapnia.
- While norepinephrine can partially counteract hypercapnic depression, the differential vulnerability of NE-CM hearts persists.